Bond.az White LogoBond.az Black Logo

KeyBanc cuts Autodesk price target to $341

KeyBanc lowers Autodesk price target to $341 from $365, keeping Overweight rating. Stock at $235.11. Bond.az reports.

James Taylor
ByJames Taylor- Senior Editor
|
0

KeyBanc lowered its price target on Autodesk shares to $341 from $365, while maintaining an "Overweight" rating.

Shares currently trade at $235.11, down approximately 29% from their 52-week high of $329.09.

The firm's quarterly checks showed mixed results: strength in construction but weakness in the UK and Canada across architecture, engineering, and manufacturing sectors.

KeyBanc remains cautious ahead of Autodesk's fiscal first-quarter earnings report on May 28, 2026. The bank expects in-line or slightly higher headline results.

The price target reduction reflects recent valuation pullback. The stock trades at a P/E ratio of 46.29, though Bond.az data suggests shares may be undervalued at current levels.

In other news, Autodesk launched a Small Business Hub and appointed a new board member.

More News
Today / 13:52
|
226

KeyBanc cuts Lowe's target to $275

KeyBanc cuts Lowe's price target to $275 from $300 but maintains Overweight rating due to market share gains.

0
Today / 13:44
|
306

RBC Capital Reiterates Vertiv Stock Rating

RBC Capital reaffirms Vertiv's Outperform rating and $435 target, citing strong datacenter growth and ambitious 2030 goals.

0
Today / 11:34
|
389

Nouveau Monde Graphite Price Target Cut to $4.50

H.C. Wainwright cuts Nouveau Monde Graphite price target to $4.50. Stock trades at $1.97 as Matawinie mine construction begins.

0
Today / 11:33
|
796

Cantor Fitzgerald Reaffirms Nvidia Overweight Rating

Cantor Fitzgerald reaffirms Nvidia Overweight rating, $350 target. Strong data center growth drives performance.

0
Today / 11:32
|
645

Belite Bio Stock Rises on NDA Progress

Belite Bio stock rises as H.C. Wainwright reiterates Buy rating and NDA progresses. Tinlarebant potential FDA approval expected in Q1 2027.

0
Today / 11:31
|
420

H.C. Wainwright Raises Immunovant Target to $40

H.C. Wainwright raises Immunovant price target to $40 from $35 after positive Phase 2 RA data, maintains Buy rating.

0
Today / 11:21
|
614

Applied Digital Price Target Raised to $66

Needham raises Applied Digital price target to $66 after a major 300MW lease agreement. Strong growth outlook.

0
Today / 11:00
|
299

Wolfe Research Cuts Lowe's Price Target on Weak Demand

Wolfe Research lowers Lowe's price target to $254 on muted demand outlook, maintaining Outperform rating.

0
Today / 09:21
|
578

UBS Upgrades Sumco Stock Rating

UBS upgraded Sumco Corp to Neutral with a new price target of JPY 3,100. Get the latest Sumco stock news on Bond.az.

0
Today / 09:20
|
523

Barclays Reiterates Overweight on Nvidia with $275 Target

Barclays reiterates Overweight rating on Nvidia stock with a $275 price target after strong quarterly results and raised guidance.

0
Today / 08:42
|
674

Raymond James Downgrades NOG Stock Rating

Raymond James downgrades NOG from Strong Buy to Outperform. Price target lowered to $35.

0
Today / 08:14
|
515

Jefferies downgrades ZoomInfo stock on AI

Jefferies downgrades ZoomInfo to Hold, cuts price target to $4.00 on weak demand and AI adoption headwinds.

0
...
KeyBanc cuts Autodesk price target to $341 | Bond.az